1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Global Cell and Gene Therapy Drug Delivery Devices Market: Focus on Product Type, Commercialized Drug Delivery Devices, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

Global Cell and Gene Therapy Drug Delivery Devices Market: Focus on Product Type, Commercialized Drug Delivery Devices, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

  • March 2021
  • 288 pages
  • ID: 6036667
  • Format: PDF
  • BIS Research

Summary

Table of Contents

Global Cell and Gene Therapy Drug Delivery Devices Market to Reach $375.13 Thousand by 2030

Market Report Coverage - Cell and Gene Therapy Drug Delivery Devices

Market Segmentation

• Product Type – Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (1.0 ml, and 0.5 ml), Prefilled Syringe (1.0 ml, and 4.0 ml), and Infusion Bags (10 ml to 50 ml, 68 ml, 60 ml, and up to 65 ml).
• Commercialized Drugs – Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, and Strimvelis

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Italy, U.K., Spain, Netherlands, Russia, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, South Korea, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)
• Latin America – Brazil, Mexico, and Rest-of-the-Latin America
• Rest-of-the-World

Growth Drivers

• Increasing Prevalence of Cancer and Chronic Diseases
• Increased Funding in Cell and Gene Therapy Market
• Rising Number of the FDA Approvals of Cell and Gene Therapies & Clinical Trials

Market Challenges

• Stringent Government Regulations
• Injuries and Infections Caused by Needles

Market Opportunities

• Strong Pipeline and Drug Approvals of Cell and Gene Therapies

Key Companies Profiled

Amgen, Inc., Bausch & Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute, Kite Pharma, Inc., Kolon Tissue Gene, inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Renova Therapeutics, Spark Therapeutics, Inc., uniQure N.V., and Vericel Corporation

Key Questions Answered in this Report:
• What are cell and gene therapy drug delivery devices?
• What is the list of commercialized cell and gene therapies available in the market?
• How did the cell and gene therapy drug delivery devices market evolve, and what is its scope in the future?
• What are the major market drivers, challenges and opportunities in the global cell and gene therapy drug delivery devices market?
• What are the key developmental strategies that are being implemented by the key players to sustain in this market?
• How did the emerging technology landscape of cell and gene therapy drug delivery devices look like?
• What will be the impact of COVID-19 on this market?
• What will be the impact of COVID-19 on cell and gene therapy drug delivery devices companies?
• What will be the impact of COVID-19 on supply chain of cell and gene therapy drug delivery devices market?
• What are the guidelines implemented by different government bodies to regulate the approval of cell and gene therapy drug delivery devices market?
• How the investments by government organizations will affect the global cell and gene therapy drug delivery devices market?
• What was the market size of the leading segments and sub-segments of the global cell and gene therapy drug delivery devices market in 2019?
• How will the industry evolve during the forecast period 2020- 2030?
• What will be the growth rate of the cell and gene therapy drug delivery devices market during the forecast period?
• How will each of the segments of the global cell and gene therapy drug delivery devices market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2030?
• Which product segment, and commercialized drug segment is expected to register the highest CAGR for the cell and gene therapy drug delivery devices market?
• What is the market size of cell and gene therapy drug delivery devices market in different countries of the world?
• Which geographical region will contribute to the highest sales of cell and gene therapy drug delivery devices market?
• What are the reimbursement scenario and regulatory structure for the cell and gene therapy drug delivery devices in different regions?
• What are the key strategies incorporated by the players of global cell and gene therapy drug delivery devices market, to sustain the competition and retain their supremacy?

Market Overview

Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge.Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy.

Cell and gene therapies may offer longer-lasting effects than traditional medicines.One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy.

Various market players are actively investing in the research and development of the cell and gene therapy industry.The players are offering improved and new products, which meet the critical needs of patients.

The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030, registering a CAGR of 16.61% during the forecast.

The growth is attributed to major drivers in this market such as increasing prevalence of cancer and chronic diseases, increased funding in cell and gene therapy market, rising need to develop novel treatment options for rare disease, and rising biopharmaceutical R&D expenditure, and rising number of the FDA approvals of cell and gene therapies & clinical trials. The market is expected to grow at a significant growth rate due to various potential opportunities of growth that lie within its domain, which include drug approvals and strong pipeline of cell and gene therapies.

Various new cell and gene-based therapy approaches use biological engineering to improve the immune system’s capacity to fight disease while sparing healthy tissues in the body.For instance, there are antibody-based therapies that can make T-cells more effective by increasing their interactions with cancer cells.

Other modifications, such as adding complexity to the CAR-T and cancer cell interaction, which can further sharpen T-cells’ cancer-targeting ability by reducing damage to normal cells. The increase in geriatric population and increasing number of cancer cases, and genetic disorders across the globe are expected to translate into a significantly higher demand for cell and gene therapy drug delivery devices market.

Furthermore, the companies are investing huge amount in research and development of cell and gene therapies and associated drug delivery devices products. The clinical trial landscape of various genetic and chronic diseases has been on the rise in the recent years, this will fuel the cell and gene therapy drug delivery devices market in future.

Within the research report, the market is segmented based on product type, commercialized drugs, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the application of precision medicine on a global level has created a buzz among companies to invest in the development of novel cell and gene therapy drug delivery devices. Due to the diverse product portfolio and intense market penetration, Novartis AG, Kite Pharma Inc., and Dendreon Pharmaceuticals LLC. have been the pioneers in this field and been the major competitors in this market. The other major contributors of the market include companies such as Vericel Corporation, Amgen Inc., Bausch & Lomb Incorporated, Spark Therapeutics, Inc., and Becton, Dickinson and Company.

Based on region, North America holds the largest share of cell and gene therapy drug delivery devices market due to substantial investments made by biotechnology and pharmaceutical companies, improved healthcare infrastructure, rise in per capita income, early availability of approved therapies, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• Netherlands
• U.K.
• Russia
• Rest-of-Europe
• Asia-Pacific
• China
• India
• Australia
• South Korea
• Japan
• Singapore
• Rest-of-Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest-of-Latin America
• Rest-of-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Gene Therapy Market Research Report by Type, by Vector Type, by Application, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • January 2022
  • 210 pages

Gene Therapy Market Research Report by Type (Antigen Gene Therapy, Cancer Gene Therapy, and Cytokine Gene Therapy), by Vector Type (Non-viral Vectors and Viral Vectors), by Application, by Region (Americas, ...

  • World
  • Gene Therapy
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on